SBRT 2016

Initial staging & histopathology

Primary

Hilar LN Adrenal

 NSCLC cT2 cN1 cM1 (adrenal), Adeno Carcinoma  Synchronous oligo-metastatic stage IV NSCLC  EGFR, BRAF, KRAS, ERBB2, ALK, ROS1 negative 08/2015

ESTRO SBRT COURSE 2016 - Matthias Guckenberger

13.06.2016

3

/